<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Barker | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/beastsort10/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/beastsort10/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Barker.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">6dd4aaa25ec2716fef9a3dd8ccd11e54</guid>
				<title>Barker posted an update: Finally, our results indicate a switch from preferential [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41578/</link>
				<pubDate>Sat, 08 Feb 2025 09:44:22 -0800</pubDate>

									<content:encoded><![CDATA[<p>Finally, our results indicate a switch from preferential cleavage of the pro-(R) to the pro-(S) carboxylate group in the CLG-IPL variant of AMDase for all substrates studied. This appears to be due to the emergence of a new hydrophobic pocket generated by the insertion of the six amino acid substitutions, into which the pro-(S) carboxylate binds.&hellip;<span class="activity-read-more" id="activity-read-more-41578"><a href="http://www.nationalboardinstitute.com/activity/p/41578/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ccb35c57646d331967f088401308351e</guid>
				<title>Barker posted an update: Molecular dynamics (MD) study of docked TLR3-vaccine complex [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39809/</link>
				<pubDate>Thu, 06 Feb 2025 10:18:02 -0800</pubDate>

									<content:encoded><![CDATA[<p>Molecular dynamics (MD) study of docked TLR3-vaccine complex delineated it to be highly stable during simulation time and the stabilization of interaction was majorly contributed by electrostatic energy. <a href="https://www.selleckchem.com/products/glpg3970.html" rel="nofollow ugc">GLPG3970 supplier</a> The docked complex also showed low deformation and increased rigidity in motion of residues during dynamics. Furthermore, in&hellip;<span class="activity-read-more" id="activity-read-more-39809"><a href="http://www.nationalboardinstitute.com/activity/p/39809/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e079887fd8edfe171bddd66aa810a783</guid>
				<title>Barker posted an update: Small Bowel Capsule Endoscopy is the first-choice technique [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35598/</link>
				<pubDate>Sat, 01 Feb 2025 10:10:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>Small Bowel Capsule Endoscopy is the first-choice technique for investigating the majority of small bowel diseases. Its most common complications are related to incomplete examinations and capsule retention. There is no consensus on how patients with previous gastrointestinal surgery should receive the capsule.</p>
<p> The primary endpoint was to&hellip;<span class="activity-read-more" id="activity-read-more-35598"><a href="http://www.nationalboardinstitute.com/activity/p/35598/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2f30ecb4c01bb7da2815ea742a2a1e39</guid>
				<title>Barker posted an update: Moreover, these changes correlate with the main histological [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33642/</link>
				<pubDate>Thu, 30 Jan 2025 10:02:29 -0800</pubDate>

									<content:encoded><![CDATA[<p>Moreover, these changes correlate with the main histological features steatosis, apoptosis, iron deposits and fibrosis. Strikingly, treatment with the repurposed drug ciclopirox improves the phosphoromic profile of CEP mice, an effect that was mirrored by the normalization of liver histology. In conclusion, these findings indicate that NMR-based&hellip;<span class="activity-read-more" id="activity-read-more-33642"><a href="http://www.nationalboardinstitute.com/activity/p/33642/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1f7f400a65a63ad00c55256fbfbb7c96</guid>
				<title>Barker posted an update: Porous organosilica microparticles consisting of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26957/</link>
				<pubDate>Tue, 28 Jan 2025 08:37:16 -0800</pubDate>

									<content:encoded><![CDATA[<p>Porous organosilica microparticles consisting of silane-derived cyclophosphazene bridges were synthesized by a surfactant-mediated sol-gel process. Starting from the substitution of hexachlorocyclotriphosphazene with allylamine, two different precursors were obtained by anchoring three or six alkoxysilane units, via a thiol-ene photoaddition&hellip;<span class="activity-read-more" id="activity-read-more-26957"><a href="http://www.nationalboardinstitute.com/activity/p/26957/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c0d3252e85cb66451eda65f4720e1bfc</guid>
				<title>Barker became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26936/</link>
				<pubDate>Tue, 28 Jan 2025 08:35:46 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>